Chondrosarcoma • miR-129-5p • SOX4 • Wnt/β-catenin signaling pathway Abstract Background/Aims: Recently, microRNAs (miRNA) have been identified as novel regulators in Chondrosarcoma (CHS). This study was aimed to identify the roles of miR-129-5p-5p in regulation of SOX4 and Wnt/β-catenin signaling pathway, as well as cell proliferation and apoptosis in chondrosarcomas. Materials and Methods: Tissue samples were obtained from chondrosarcoma patients. Immunohistochemistry, real-time quantitative RT-PCR (RT-qPCR) and western blot analysis were performed to detect the expressions of miR-129-5p and SOX4. Luciferase assay was conducted to confirm that miR-129-5p directly targeted SOX4 mRNA. Manipulations of miR-129-5p and SOX4 expression were achieved through cell transfection. Cell proliferation, migration and apoptosis were evaluated by CCK-8 assay, colony forming assay, wound healing assay and flow cytometry in vitro. For in vivo experiment, the tumor xenograft model was established to evaluate the effects of miR-129-5p and SOX4 on chondrosarcomas. Results: The expression of miR-129-5p was significantly down-regulated in chondrosarcoma tissues as well as cells in comparison with normal ones, while SOX4 was overactivated. Further studies suggested that miR-129-5p suppressed cell proliferation, migration and promoted apoptosis by inhibiting SOX4 and Wnt/β-catenin pathway. Conclusion: MiR-129-5p inhibits the Wnt/β-catenin signaling pathway by targeting SOX4 and further suppresses cell proliferation, migration and promotes apoptosis in chondrosarcomas.
Introduction
Chondrosarcoma (CHS), a malignant tumor with pure hyaline cartilage differentiation, is the second most frequent primary bone malignancy after osteosarcoma [1, 2] . It is a rare disease that accounts for approximately 3 new cases per 1000,000 population annually and mainly occurs in adults [2] . Chondrosarcomas are notoriously resistant to conventional chemotherapy and radiotherapy for lack of vascularity in cartilage which definitely hinders drug delivery and thus, chondrosarcomas are usually settled by surgery [3] . Unfortunately, a majority of patients recur with higher-grade chondrosarcomas which are often lethal to them (10-year survival rate of 29%) [3, 4] . Therefore, alternative strategies are urgently needed in chondrosarcoma diagnosis and therapeutics.
MicroRNAs (miRNAs) are a series of short (approximately consisting of 19-25 nucleotides) non-coding RNA molecules that have vital regulatory functions in modulating target gene expression through translational repression or mRNA cleavage [5, 6] . MiRNAs are often aberrantly expressed and serve as tumor suppressors or oncogenes in carcinogenesis including chondrosarcomas [1, 7] . Previous studies have revealed that miR-129 plays as a tumor suppressor in many cancers, such as breast cancer, lung cancer, prostate cancer, hepatocellular cancer and osteosarcoma [8] [9] [10] [11] [12] [13] , but few have focused on its corresponding functions and mechanisms in chondrosarcomas.
SOX4 is a member of the SOX (SRY-related HMG-box) family of transcription factors which involves in various physiological processes such as chondrogenesis [1, 14, 15] . Recently, SOX4 has attracted more attention since it is related with various malignant cancers. Previous studies showed that SOX4 expression was upregulated in many types of human cancers and over-expression of SOX4 contributed to an increased risk of death in some cancer patients [15] . On the other hand, genome-wide promoter analysis indicated that SOX4 was associated with a number of transcription factors, including E2F1, E2F4 and c-MYC [1] . Moreover, it was demonstrated that SOX4 over-expression was a malignant prognostic factor for patients with low-grade chondrosarcomas, and that SOX4 functioned as an oncogene in chondrosarcoma cells [1] , which provided evidences in potential correlation between SOX4 and chondrosarcoma development.
The Wnt/β-catenin pathway requires Wnt ligand binding to Frizzled receptors as well as LRP5/6 co-receptors to initiate intracellular signaling via β-catenin nuclear translocation. Wnt/β-catenin axis affects biological events by targeting series of genes such as C-myc and Cyclin D1 which are known related to cell cycle regulation [16, 17] . Deregulation of the canonical Wnt/β-catenin pathway is commonly observed in human cancers, and lots of evidences implied that the aberrant activation of the Wnt/β-catenin signaling pathway may be associated with cancer development including chondrosarcoma [16, [18] [19] [20] [21] . In lung cancer, the Wnt signaling components were aberrantly expressed [22] and the overexpression of Wnt1 enhanced the aggressiveness of non-small cell lung cancers [23] . Jiang et al. [24] demonstrated that activated Wnt/β-catenin signaling pathway could stimulate prostate cancer growth in bone and soft tissues. Chen et al. [25] also found that similar aberrant activation of the Wnt/β-catenin signaling pathway occured in chondrosarcoma cells and regulated cell proliferation.
There have been some reports about the interaction between two of miR-129, SOX4 and Wnt/β-catenin signaling pathway in cancers. Kang et al. suggested that the deregulation of miR-129-2 resulted in aberrant SOX4 expression in esophageal cancer [26] . In addition, Huang et al. dug out evidences indicating that up-regulation of SOX4 was inversely correlated with the epigenetic silencing function of miR-129-2 in gastric cancer, and the restoration of miR-129-2 down-regulated SOX4 expression [27] . Furthermore, it has been reported that aberrant activation of the Wnt signaling pathway drove the proliferation of chondrosarcoma cells [15] , and SOX4 amplified the Wnt/β-catenin signaling pathway's effect on proliferation of melanoma cells [28, 29] . However, none has investigated the pathogenesis by taking miR-129-5p, SOX4 and Wnt/β-catenin signaling into consideration simultaneously.
In the current study, we have systematically validated the relationship among the Wnt/ β-catenin signaling pathway, SOX4 and miR-129-5p in chondrosarcomas and verified the molecular mechanism of miR-129-5p on suppressing proliferation, migration and promoting apoptosis of chondrosarcoma cells.
Materials and Methods

Clinical samples
The chondrosarcoma biopsy specimens were obtained from 92 patients (47 males and 45 females) in Huaihe Hospital of Henan University between Mar 2014 and Oct 2015. Samples were pathologically confirmed and collected during surgical operation before conducting radiotherapy or chemotherapy. All tissue samples were under consent from patients and approved for study by the Ethics Committee of Huaihe Hospital of Henan University.
Immunohistochemistry
Immunohistochemical analysis of SOX4 was performed on tissue samples with the EnVision two-step method as previously described [30] . Conventional dewaxing and antigen microwave thermal retrieval was performed on four-micron-thick serial sections of formalin-fixed and paraffin-embedded tissues. The sections were incubated in a 3% hydrogen peroxide solution to block endogenous peroxidase activity. Primary antibodies (Rabbit anti-human SOX4 monoclonal antibody, 1:400; ab80261, Abcam, Cambridge, MA, USA) were applied to the sections at a refrigerated temperature of 4 o C overnight. Next, the sections were incubated for 20 minutes at room temperature. Polymerase auxiliary agent was then added and incubated for another 30 minutes at room temperature. Subsequently, secondary antibodies (Bioss, Beijing, China) were applied. The reaction product was visualized by incubation with the substrate/chromogen 3, 3′-diaminobenzidine (DAB, D8001, Sigma-Aldrich, St. Louis, MO, USA). Finally, the sections were counterstained with 0.02% Hematoxylin (H3136, Sigma-Aldrich, St. Louis, MO, USA).
Cells lines
The human chondrosarcoma cell line JJ012 was kindly provided by from Dr. Sean P. Scully (University of Miami School of Medicine, Miami, FL), while human chondrosarcoma cell line, SW1353, was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). IN addition, the normal chondrocyte cell line CHON-002, coming from bone tissues of human as well, were purchased from Shanghai Jimian Industrial Co., Ltd. JJ012, HS18.90, SW1353 and CHON-002 cells were authenticated with the PowerPlex® 18D kit (Promega, Madison WI) for short tandem repeat (STR) DNA analysis at their arrival in the laboratory and periodically thereafter. Then cell lines were screened for the contaminations of mycoplasma routinely as previously described [31] . After confirmed mycoplasma-free, cells were cultured in Dulbecco modified Eagle medium (DMEM; Gibco, Carlsbad, CA) with 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA) under a humidified atmosphere of 5% CO 2 at 37 ℃.
Transfection
MiR-129-5p mimics, SOX4 cDNA, SOX4 siRNA1 and SOX4 siRNA2 were obtained from RiboBio Co., Ltd. (Guangzhou, China). PcDNA3.1 vector (Thermo Fisher Scientific, Waltham, MA) was employed to generate miR-129-5p, SOX4, SOX4 siRNA1 or SOX4 siRNA2 expression plasmid, and the empty pcDNA3.1 vector was as a negative control. Transfection to SW1353 and JJ012 cells was performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to manufacturer's protocol.
CCK-8 assay
Cell viability was evaluated with the Cell Counting Kit-8 (CCK-8; Dojindo, Japan). Cells were seeded in 96 well-plates at a density of 3 × 10 3 per well and incubated over different time (24 hrs, 48 hrs, and 72 hrs). The absorbance value of each well at 450 nm was measured using a microplate reader (BioTek, Biotek Winooski, Vermont, USA). All experiments were repeated in triplicate.
Colony formation assay
Cells were seeded in 6-well plates at a density of 5 × 10 2 cells/well and incubated for two weeks. After crystal violet staining, colonies were counted under a microscope (Olympus Corporation, Tokyo, Japan).
Wound healing assay
Cells were seeded at a density of 2 × 10 5 cells/well in 6-well plates. When the cells reached 80% confluence, a wound gap was scratched vertically in the middle of each well with a pipette tip. After being washed with PBS three times, cells were incubated in growth medium. The wound widths were photographed and measured under a microscope after 0 hr and 24 hrs.
Transwell assay
Cells in five different groups were seeded into the upper chambers (8μm pore size; Corning Incorporated, Corning, NY, USA) at the density of 1 × 10 4 cells/well with serum-free medium, and medium with 20% FBS was added into the lower chamber. Before the inoculation of the cancer cells, the upper chambers were additionally coated with Matrigel basement membrane matrix (354234, BD Bioscience, San Jose, CA, USA) in the invasion assay. After incubation for 24 hours at 37 °C in 5% CO 2 , the cells were fixed by 4.0% paraformaldehyde for 30 min and stained with 0.1% crystal violet for 20 min. The swabs were used to remove the cells on the upper side of filters, followed with washes with PBS for three times. Then the number of cells was counted in five randomly selected fields per well under a microscope.
Flow cytometry
For apoptosis assays, staining with FITC-Annexin V and propidium iodide (PI) was performed using the Annexin V-FITC/PI Apoptosis Detection Kit (BD Biosciences, San Jose, CA) and the apoptosis rates were analyzed by flow cytometry. The Annexin V-and PI+ represented necrotic cells, the Annexin V+ and PI+ represented late apoptotic cell, the Annexin V+ and PI-represented early apoptotic cell, and the Annexin V-and PI-represented normal cells.
Luciferase reporter assay
The SOX4 3' UTR segments containing the miR-129-5p binding sites were amplified by RT-PCR and the mutant segments were also designed. The couple of oligonucleotides were then inserted into pmirGLO, Dual-Luciferase miRNA Target Expression Vector (Promega, Madison, WI), and subsequently sequenced to prevent any mutant. HEK293 cells purchased from ATCC were plated in 24-well plates and co-transfected with miR-129-5p mimics or empty pcDNA3.1 vector with recombinant pmirGLO. The relative Luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI) 48 h after co-transfection.
Tumor formation in nude mice
Sixty SCID nude mice (Laboratory Animal Center of Henan University) at an average age of 4 weeks were obtained to build tumor growth models. The mice were randomly separated into 10 groups. Mice of three groups were each subcutaneously injected with 1×10 6 SW1353 cells or JJ012 cells transfected with miR-129-5p, SOX4 siRNA1, SOX4 siRNA2 or miR-129-5p+SOX4 (co-transfected with miR-129-5p and SOX4) respectively and others with equivalent number of cells expressing empty vector. The tumor was measured every three days with a caliper, and the volume size was calculated based on the formula: V (mm
)/2 (L and W represent tumor length and width, respectively). Mice were sacrificed at the end of the observation period (24 days after the injection) and tumors were taken out for further studies.
Real-time quantitative RT-PCR (qRT-PCR)
Total RNA extraction from tissues and cells was conducted with the Trizol reagent kit (Ambion, Austin, TX) according to the manufacturer's instructions. The corresponding cDNA was obtained using the reverse transcription Kit (Thermo Fisher Scientific, Waltham, MA). Real-time quantitative PCR assay was performed to detect the relative expression levels of miR-129-5p and SOX4 with U6 as an endogenous control for miRNA and GAPDH for mRNA (Primers were listed in Table 1 ). The relative expression levels were calculated with the 2 -△△Ct method and experiments were repeated in triplicate. 
Western blot
Cells were lysed with M-PER Protein Extraction Reagent (Pierce, Rockford, IL) and supplemented with protease inhibitors. Nucleoproteins were extracted using the CelLytic™ NuCLEAR™ extraction Kit (NXTRACT, Sigma-Aldrich, St. Louis, MO, USA). Protein concentrations were determined using a BCA protein assay kit (QPBCA, Sigma-Aldrich, St. Louis, MO, USA). Equal amount of protein was separated using SDSpolyacrylamide gel electrophoresis, transferred to equilibrated polyvinylidene difluoride membranes and blocked in 5% non-fat milk Tris-buffered saline (pH 7.4) containing 0.1% Tris buffered saline with Tween (TBST) for 2 hrs. Then the membranes were incubated over night at 4 o C with primary antibodies purchased from Sigma-Aldrich (St. Louis, MO, USA) against SOX4 (SAB2108306), β-catenin (C2206), Cyclin D1 (SAB4503499), C-myc (ROAMYC), nuclear β-catenin (C8249), histone H3 (H9289), β-actin (A1978), Mcl-1 (M8434) and Bcl-2 (S3335), while anti-cleaved caspase-3 from Abcam (ab32351, Cambridge, MA, USA). Next, membranes were incubated with secondary antibody (Pierce, Rockford, IL) for 1 hr at room temperature. Proteins were visualized with the ECL Plus Western Blotting Detection Reagents (Amersham Biosciences, USA) and detected with enhanced chemiluminescence.
Statistical Method SPSS 19.0 (Chicago, Illinois, USA) and GraphPad Prism (Version 6.0; La Jolla, CA, USA) were used for data analysis. The measurement data was expressed as mean ± standard deviation (SD). The data were analyzed with Student's t test when only two groups were compared. And one-way analysis of variance (ANOVA) together with Fisher's least significant difference (LSD) test was conducted to evaluate the differences among the multiple groups. P<0.05 was considered statistically significant.
Results
The up-regulation of SOX4 and down-regulation of miR-129-5p in chondrosarcoma tissues and cells
The immunohistochemistry results indicated that tumor tissues with higher grades showed higher SOX4 expression (Fig. 1A) . MiR-129-5p exhibited a significant lower expression level in both tumor tissues (P<0.05, Fig. 1B ) and human chondrosarcoma cell lines (JJ012 and SW1353) (P<0.05, Fig. 1D ) according to qRT-PCR analysis. On the contrary, qRT-PCR confirmed higher expression of SOX4 at mRNA level in tumor tissues (P<0.05, Fig.  1C ) as well as two different human chondrosarcoma cell lines (P<0.05, Fig. 1E ). In addition, the expression of miR-129-5p was negative correlated with SOX4 at tissue level and cell level (for all online suppl. material, see www.karger.com/doi/10.1159/ 000477323, Fig. S1 ). The protein expression of SOX4 is significant higher in tumor tissues, SW1353 cells and JJ012 cells compared to normal samples (P<0.05, Fig. 1F-G) . Moreover, the expression of SOX4 was measured at both mRNA and protein level in normal chondrocytes CHON-002, in which miR-129-5p was inhibited in the pilot experiment. However, no remarkable differences were observed, and the corresponding data were not shown.
MiR-129-5p directly targeted SOX4
TargetScan and miRBase suggested that 3'UTR of SOX4 contained the miR-129-5p seed sites ( Fig. 2A) . To determine whether miR-129-5p could actually target SOX4, dual-luciferase analysis was conducted after HEK293 cells were co-transfected with the SOX4-wt (wild-type 3'UTR) or SOX4-mut (with mutant sites) reporter plasmids and miR-129-5p or miR-NC respectively. The results showed that miR-129-5p down-regulated the luciferase activity of SOX4-wt plasmid (P<0.05), but had no effects on that of SOX4-mut plasmid (P>0.05, Fig.  2B ). The results manifested that SOX4 was one of miR-129-5p targets. Furthermore, the expression level of SOX4 in chondrosarcoma cells (SW1353 cells and JJ012 cells) with miR-129-5p over-expressed was evaluated using Western blot. As show in Fig. 2C-D , miR-129-5p down-regulated the protein level of SOX4 in both SW1353 cells and JJ012 cells.
MiR-129-5p inhibited the Wnt/β-catenin signaling pathway by targeting SOX4
The Wnt/β-catenin-related proteins in SW1353 cells and JJ012 cells were investigated with miR-129-5p over-expressed or SOX4 suppressed. As shown in Fig. 3A and see in SW1353 and JJ012 cells. Each group has three parallels, and each sample was measured thrice. The student's t-test was used to analyze the difference between miR-129-5p and NC groups, * P<0.05.
groups with SOX4 inhibited cells (SOX4 siRNA1 group and SOX4 siRNA2 group) (P<0.05). In addition, SOX4 overexpression antagonized the effects of miR-129-5p on the expressions of SOX4, β-catenin, Cyclin D1 and C-myc in whole cells and β-catenin in cell nucleus (P<0.05) in both SW1353 cells and JJ012 cells.
MiR-129-5p supressed proliferation, migration and promoted apoptosis of chondrosarcoma cells
CCK-8 proliferation assay and colony formation assay were carried out in SW1353 cells and JJ012 cells to investigate cell viability and proliferation. As suggested by Fig. 3 B-C and see Each group has three parallels, and each sample was measured for three times. ANOVA was performed for the comparison among control, miR-129-5p, SOX4 siR-NA1, SOX4 siRNA2 and miR-129-5p+SOX4 groups, followed with LSD test for pairwise comparisons. The p-value of ANOVA test was less than 0.05. * P<0.05 verse control group, # P<0.05 verse miR-129-5p+SOX4 group in LSD test.
supplementary material, Fig. S3A , SW1353 cells and JJ012 cells transfected with exogenous miR-129-5p or SOX4 siRNA (SOX4 siRNA1 and SOX4 siRNA2) had lower proliferation rate compared to the control group (P<0.05), while over-expression of SOX4 antagonized the inhibitory effect of miR-129-5p on cell proliferation. As Fig. 3D -E and (see supplementary material) Fig. S3B-C shown, the ability of cell migration was suppressed in cells transfected with miR-129-5p or SOX4 siRNA (SOX4 siRNA1 and SOX4 siRNA2) (P<0.05). Moreover, the results of invasion assay indicated that the invasion ability of SW1353 cells and JJ012 cells was inhibited by miR-129-5p and SOX4 siRNA (P<0.05, Fig. 4F , and see supplementary material, Fig. S3D) .
Apoptosis was subsequently detected via AnnexinV-PI double staining flow analysis and the results were shown in Fig. 4 A and see supplementary material, Fig. S4A . We found that transfection of miR-129-5p or SOX4 siRNA (SOX4 siRNA1 and SOX4 siRNA2) increased the proportion of apoptotic cells, whereas up-regulation of SOX4 antagonized the effect of miR-129-5p (P<0.05). In addition, we detected the expressions of apoptosis-related proteins including Mcl-1, Bcl-2 and caspase-3. Compared with control group and miR-129-5p+SOX4 group, miR-129-5p group and SOX4 siRNA (SOX4 siRNA1 and SOX4 siRNA2) group had significantly lower expressions of Mcl-1, Bcl-2, and higher expression of cleaved caspase-3 (P<0.05, Fig. 4B, see supplementary material, Fig. S4B-D) . Thus, all these evidences manifested that miR-129-5p suppressed proliferation, migration and promoted apoptosis of SW1353 cells and JJ012 cells by targeting SOX4.
MiR-129-5p suppressed formation of chondrosarcoma xenografts by targeting SOX4
Given that miR-129-5p acted as a chondrosarcoma supressor in vitro, we further assessed its effect in vivo. As shown in Fig. 5A , tumors induced with miR-129-5p overexpressed cells or SOX4 blocked cells grew at a much slower rate. Significant reductions in tumor size were observed at the termination of experiment (P<0.05). Moreover, in tumor tissues, miR-129-5p was significantly over-expressed in both miR-129-5p group and miR- 129-5p+SOX4 group (P<0.05), while the expression of SOX4 was obviously inhibited in miR-129-5p group, SOX4 siRNA1 group and SOX4 siRNA2 group (P<0.05, Fig. 5B-C) . Therefore, miR-129-5p suppressed formation of chondrosarcoma xenografts by targeting SOX4 and these results supported our in vitro findings.
Discussion
Chondrosarcoma is a lethal disease with poor survival rates particularly when it progresses into higher grade chondrosarcoma. However, it is a pity that the conventional chemotherapy is ineffective for it due to the avascular nature of cartilages [2, 3, 32] . Therefore, it is essential to focus on the tumorigenesis mechanisms of chondrosarcomas in order to discover the way to manage this disease effectively. Recently, an increasing number of studies have indicated that miRNAs were often aberrantly expressed in cancer cells and served as tumor suppressors or oncogenes in carcinogenesis [1, 7] . Hence, we have every reason to believe that identification of chondrosarcoma related miRNAs as well as their downstream targets, their biological functions and the molecular mechanism would contribute to chondrosarcoma treatments.
In this study, we sought to investigate the role of miR-129-5p on chondrosarcomas and the possible molecular mechanism. We had performed in-vitro and in-vivo experiments to evaluate the effects of miR-129-5p on chondrosarcoma cell proliferation and migration by altering its expression level via cell transfection. In addition, SOX4 is predicted as one of the targets of miR-129-5p by both miRBase (http://www.mirbase.org/) and Targetscan 7.1 (http://www.targetscan.org/vert_71/). And our results of luciferase reporter assay were consistent with the prediction. Furthermore, we have identified that miR-129-5p regulates Wnt/β-catenin signaling pathway by targeting SOX4.
On the basis of our study, miR-129-5p showed decreased expression levels in chondrosarcoma tumor, which was in accordance with previous studies performed in other cancers [33] [34] [35] . Thus, it was surmisable that miR-129-5p might serve as a tumor suppressor. Na et al. reported that the invasion and migration of laryngeal cancer cells were inhibited when the expression of miR-129 was up-regulated [36] . Likewise, Xiao et al. suggested that miR-129 exerted suppressive effects on cell proliferation, migration and invasion in lung cancer [10] . Similarly, our results also indicated that miR-129-5p repressed the development of chondrosarcoma. Up-regulation of miR-129-5p attenuated cell proliferation and migration while stimulated apoptosis in chondrosarcomas.
On the other hand, we also studied the biological functions of SOX4 in chondrosarcomas cells. SOX4 was previously considered to be an oncogene according to many other researches and was confirmed with our findings in chondrosarcomas. We determined that SOX4 was upregulated in chondrosarcomas cells, which was in agreement with the results of Lu et al. [1] . Next, we blocked the expression of SOX4 with SOX4 siRNA1 or SOX4 siRNA2 and observed similar inhibitory effects on cell viability and mobility as overexpression of miR-129-5p. For this reason, we subsequently focused on the specific relationship between miR-129-5p and SOX4 as well as the potential downstream signaling pathways.
Our further studies indicated that SOX4 and Wnt/β-catenin were involved in the molecular mechanism of miR-129-5p's tumor suppressive effect. There have been some studies investigating the regulatory relationship among miR-129-5p, SOX4 and Wnt/β-catenin pathway. For example, Li et al. reported that increasing miR-129 results in a decreased expression of the tumor suppressor APC, thereby activating the Wnt signaling pathway in laryngeal squamous cell carcinoma (LSCC) [37] . Saegusa et al. demonstrated that SOX4 positively regulated β-catenin through TCF4 and resulted in promotion of cell proliferation of endometrial carcinomas [38] . Inoue et al. have indicated that SOX4 could form transcriptional complexes with β-catenin and promoted β-catenin mediated transcription of the Slug gene in uterine carcinosarcoma [39] . Different with previous studies, we designed and conducted experiments by considering miR-129-5p, SOX4 and the Wnt/β-catenin pathway altogether. We verified the regulator relationship between miR-129-5p and SOX4 at first and our results suggested that miR-129-5p directly targeted SOX4. Subsequently, we manipulated miR-129-5p or SOX4 expression through cell transfection and observed abnormal expression of β-catenin as well as the downstream targets of the Wnt/β-catenin pathway (CyclinD1 and C-myc) in chondrosarcoma cells. With all these evidences, we determined that miR-129-5p regulated Wnt/β-catenin pathway by targeting SOX4.
In conclusion, our study demonstrates that miR-129-5p can inhibit the over-activation of the Wnt/β-catenin signaling pathway via targeting SOX4 and further regulate proliferation, migration of chondrosarcoma cells.
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